Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review

There is a pressing need for effective therapeutics for coronavirus disease 2019 (COVID-19), the respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The process of drug development is a costly and meticulously paced process, where progress is often hinde...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Argus M., Hoffman, Tyler, Luu, Bao Q., Ashammakhi, Nureddin, Li, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213042/
https://www.ncbi.nlm.nih.gov/pubmed/34178414
http://dx.doi.org/10.1007/s42242-021-00136-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213042/
https://www.ncbi.nlm.nih.gov/pubmed/34178414
http://dx.doi.org/10.1007/s42242-021-00136-5

Ejemplares similares